Mechanisms of relaxing response induced by rat/mouse hemokinin-1 in porcine coronary arteries: roles of potassium ion and nitric oxide.
Yuan Long, Cai-Yun Fu, Xiao-Zhu Tian, Juan Chen, Min Han, Rui Wang
Index: Eur. J. Pharmacol. 569(1-2) , 119-25, (2007)
Full Text: HTML
Abstract
Rat and mouse hemokinin-1(r/m hemokinin-1) is a recently described member of the tachykinin family whose cardiovascular functions are not fully understood. In this study, we investigated the mechanisms of the relaxing response induced by r/m hemokinin-1 in isolated porcine coronary arteries by using a specific antagonist of tachykinin NK(1) receptor (SR140333), a nitric oxide synthase inhibitor N(omega)-nitro-L-arginine (L-NNA), and 1H-[1,2,4] Oxadiazolo [4,3-a] quinoxalin-1-one (ODQ), a blocker of cGMP production. r/m Hemokinin-1 (10(-12)-10(-6 )M) evoked a marked endothelium-dependent vasodilatation (E(max)=121.12+/-10.6% and 91.79+/-2.39% in 10(-6) M PGF(2)alpha and 30 mM KCl precontracted arterial rings, respectively) of coronary arteries mediated by activation of endothelial tachykinin NK(1) receptors. Two components contributed to this r/m hemokinin-1-elicited vasodilatation, the first of which was endothelium-derived hyperpolarizing factor (EDHF), which played a major role. This EDHF was identified as a potassium current through certain kinds of potassium channels on the endothelial cell membrane of porcine coronary arteries. Specific antagonists of Ca(2+)-activated K(+) channels (dequalinium and clotrimazole) did not have an inhibitory effect on the r/m hemokinin-1-induced vasodilatation, whereas they did on the substance P-induced vasodilatation. When potassium ion efflux was impaired by a high K(+) concentration (30 mM) or removal of K(+) from the surroundings, NO synthesis was triggered by r/m hemokinin-1 to produce an equivalent EDHF (K(+))-independent vasorelaxation as a compensatory mechanism.
Related Compounds
Related Articles:
Antimicrobial topical agents used in the vagina.
2011-01-01
[Curr. Probl. Dermatol. 40 , 36-47, (2011)]
2014-07-01
[Leuk. Res. 38(7) , 795-803, (2014)]
2012-01-01
[J. Pharmacol. Sci. 118(2) , 156-60, (2012)]
2009-06-19
[J. Chromatogr. A. 1216(25) , 5052-6, (2009)]
2013-11-01
[J. Steroid Biochem. Mol. Biol. 138 , 267-72, (2013)]